Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Unicycive Therapeutics Inc
(NQ:
UNCY
)
0.4781
-0.0063 (-1.30%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Unicycive Therapeutics Inc
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Friday's After-Market Session
October 11, 2024
Via
Benzinga
UNCY Stock Earnings: Unicycive Therapeutics Beats EPS for Q2 2024
August 14, 2024
UNCY stock results show that Unicycive Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
July 19, 2024
Pre-market stock movers are a hot topic on Friday as we check out all of the stories affecting shares on the last day of trading this week!
Via
InvestorPlace
Greenbrier, Fortress Biotech And 3 Stocks To Watch Heading Into Monday
July 08, 2024
Via
Benzinga
Where Unicycive Therapeutics Stands With Analysts
August 16, 2023
Via
Benzinga
Analyst Expectations for Unicycive Therapeutics's Future
July 19, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
June 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
May 28, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 22, 2024
Via
Benzinga
UNCY Stock Earnings: Unicycive Therapeutics Misses EPS for Q1 2024
May 13, 2024
UNCY stock results show that Unicycive Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
UNCY Stock Earnings: Unicycive Therapeutics Misses EPS for Q4 2023
March 28, 2024
UNCY stock results show that Unicycive Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 14, 2024
Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
March 07, 2024
Via
Benzinga
Why 3M Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 23, 2024
Shares of 3M Company (NYSE: MMM) fell sharply during Tuesday’s session after the company reported better-than-expected fourth-quarter EPS, but issued FY24 EPS guidance below estimates.
Via
Benzinga
Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
January 22, 2024
Shares of Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose sharply in today’s pre-market trading after the company announced an agreement to divest ophthalmology franchise to Sandoz in $170 million...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
January 22, 2024
We're starting the trading week with a breakdown of the biggest pre-market stock movers worth knowing about on Monday!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
January 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 23, 2023
Via
Benzinga
The 7 Most Undervalued Penny Stocks to Buy in October 2023
October 06, 2023
Undervalued penny stocks offer tremendous return for investors with an appetite for risk but these shares are relatively safe as well.
Via
InvestorPlace
Nasdaq Jumps 200 Points; Baudax Bio Shares Spike Higher
June 30, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1.5% on Friday. The Dow traded up 0.93% to 34,439.75 while the NASDAQ rose 1.54% to 13,800.92. The S&P 500,...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 30, 2023
Via
Benzinga
Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 30, 2023
Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top...
Via
Benzinga
Crude Oil Rises Over 1%; Fed's Preferred Inflation Gauge Slows In May
June 30, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 1% on Friday. The Dow traded up 0.62% to 34,333.42 while the NASDAQ rose 1.37% to 13,777.52. The S&P 500,...
Via
Benzinga
Why Is Enphase Energy (ENPH) Stock Up Today?
June 30, 2023
Enphase Energy (ENPH) stock is on the rise Friday as investors react to the company expanding its distribution partnership in Europe.
Via
InvestorPlace
XPEV Stock Alert: Xpeng’s SUV Pricing Beats Out Tesla’s Model Y
June 30, 2023
Xpeng (XPEV) stock is rallying higher on Friday after the electric vehicle (EV) company priced its G6 SUV below Tesla's (TSLA) Model Y.
Via
InvestorPlace
Why Is Unicycive Therapeutics (UNCY) Down 24% Today?
June 30, 2023
Unicycive Therapeutics (UNCY) stock is falling on Friday after the medical company provided investors with an update from regulators.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 30, 2023
Via
Benzinga
Why Are Unicycive Therapeutics Shares Trading Lower Today
June 30, 2023
Unicycive Therapeutics Inc (NASDAQ: UNCY) provided an update based on recent interactions with the FDA concerning the company's New Drug Application (NDA) for lanthanum dioxycarbonate (LDC),
Via
Benzinga
Why Renalytix Are Trading Higher By Over 48%; Here Are 20 Stocks Moving Premarket
June 30, 2023
Gainers Renalytix Plc (NASDAQ: RNLX) shares surged 48.7% to $3.02 in pre-market trading after the company received FDA De Novo marketing authorization for its KidneyIntelX.dkd prognostic test.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.